May 21, 2020 / 11:14 AM / 17 days ago

BRIEF-Anavex Life Sciences Announces Initiation Of First-In-Human Phase 1 Study Of Anavex®3-71

May 21 (Reuters) - Anavex Life Sciences Corp:

* ANAVEX LIFE SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN PHASE 1 STUDY OF ANAVEX®3-71 (AF710B) Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below